Baker, Laura A.
Holliday, Holly
Roden, Daniel
Krisp, Christoph
Wu, Sunny Z.
Junankar, Simon
Serandour, Aurelien A.
Mohammed, Hisham
Nair, Radhika
Sankaranarayanan, Geetha
Law, Andrew M. K.
McFarland, Andrea
Simpson, Peter T.
Lakhani, Sunil
Dodson, Eoin
Selinger, Christina
Anderson, Lyndal
Samimi, Goli
Hacker, Neville F.
Lim, Elgene
Ormandy, Christopher J.
Naylor, Matthew J.
Simpson, Kaylene
Nikolic, Iva
O’Toole, Sandra
Kaplan, Warren
Cowley, Mark J.
Carroll, Jason S.
Molloy, Mark
Swarbrick, Alexander http://orcid.org/0000-0002-3051-5676
Funding for this research was provided by:
National Health and Medical Research Council
Article History
Received: 1 March 2020
Accepted: 1 June 2020
First Online: 11 June 2020
Ethics approval and consent to participate
: Mouse PDX experiments were conducted under the Garvan Institute ethical approval number 12/11. Breast cancer cohorts were obtained under the Garvan Institute ethical approval number HREC 08/145. Ovarian cancer cohort was obtained under the Human Research Ethics Committee of the Sydney South East Area Hospital Service Northern Section (00/115).
: Not applicable.
: The authors declare no competing interests.